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) exclusively binds to and inhibits CDK4 and CDK6. 1 Initiation of the cell cycle occurs when a quiescent cell (in G 0 ) is stimulated with appropriate mitogenic stimulus. This event induces expression of D-type cyclins that bind to CDK4 and CDK6, and then enter the nucleus. Active cyclin D-dependent kinases phosphorylate the retinoblastoma protein (Rb) in mid-G 1 . 1 Rb is then phosphorylated on additional sites by the cyclin E/CDK2 complex, and this event leads to disruption of Rb association with the transcription factor complex E2F, release of active E2F, and subsequent transcription of genes necessary for DNA synthesis, such as DNA polymerase ␣ and thymidine kinase. 2 Cyclin A-and B-dependent kinases maintain Rb in a hyperphosphorylated form during S, G 2 , and M. 1
Cell Cycle Progression and Cell Migration Are Closely Linked
Arterial smooth muscle cells (SMCs) in the normal arterial wall are quiescent and stationary. It is believed that injury of the artery, for example, by mechanical means, inflammatory processes, hypertension, or diabetes, causes various cytokines and growth factors to "activate" the SMCs, thereby increasing growth factor receptor expression and the ability of the SMC to proliferate and migrate. 3 Thus, proliferation and migration of SMCs are commonly believed to contribute to atherosclerosis, and restenosis after coronary angioplasty and stenting. 4, 5 Proliferation and migration of SMCs also occur during normal development of the cardiovascular system. It has long been known that quiescent SMCs have a low ability to undergo migration and chemotaxis, 6 and that many growth factors induce both cell proliferation and cell migration. A central question in vascular biology is whether the cell cycle regulates the ability of cells to move. 7 Several observations show that there is a close link between cell cycle progression and cell migration. For example, it has been demonstrated that rapamycin, a macrolide antibiotic, inhibits both G 1 to S transition and migration of SMCs, 8 and that this effects is reduced in SMCs derived from p27 Kip1 -deficient mice, 9 suggesting a role for CDKs and p27
Kip1 in SMC migration. However, rapamycin also induces effects that are independent of p27 Kip1 . 9,10 Overexpression of any one of p27 Kip1 , p21 Cip1 or a nonphosphorylatable form of Rb results in reduced neointimal thickening after angioplasty in rodents and pigs. [11] [12] [13] [14] [15] This effect is due, at least in part, to reduced SMC proliferation. Although SMC migration is difficult to measure in in vivo models, due to lack of specific markers, the reduced neointimal thickening observed after overexpression of p27 Kip1 , p21 Cip1 , or the Rb mutant most likely also is due to reduced SMC migration from the media into the neointima.
In this issue of Circulation Research, Díez-Juan and Andrés 16 extend these observations by showing that migration of rat SMCs and NIH-3T3 cells is directly dependent on CDK activity and downstream Rb phosphorylation. In keeping with previous studies, 9,17 overexpression of physiologically relevant levels of p27 Kip1 led to reduced cell migration. 16 The following new observations are now provided by Díez-Juan and Andrés. 16 First, overexpression of a mutant of p27 Kip1 with impaired CDK inhibitory activity did not inhibit cell migration or proliferation, which indicates that the inhibitory effects of p27 Kip1 are likely to be mediated by reduced CDK activity. Second, forced expression of a phosphorylation-deficient Rb mutant insensitive to CDKmediated inactivation and subsequent E2F activation (see Figure) led to reduced cell proliferation and cell migration. Third, overexpression of the E1A oncoprotein, which associates with Rb and results in release of E2F from Rb in a CDK-independent manner, could overcome the inhibitory effects of overexpressed p27 Kip1 on cell proliferation and cell migration without restoring CDK activity. These observations convincingly demonstrate that cell cycle events regulate cell migration.
phase, whereas cells in late S or G 2 /M have a lower, or no, ability to move. 18 -22 Accordingly, many agents and gene products that block SMC proliferation also inhibit migration of SMCs. 8, [23] [24] [25] [26] [27] How is this coordinated regulation of cell proliferation and cell migration mediated? One likely possibility, suggested by the studies of Díez-Juan and Andrés, 16 is that specific signals required for G 1 /S transition, such as CDK2 activation and release of E2F after Rb phosphorylation, directly affect events required for cell migration. Indeed, cell cycle arrest induced by overexpression of p27 Kip1 correlated with the loss of lamellipodia formation, actin reorganization, and focal adhesion reorganization, without affecting cell adhesion. 16 Interestingly, there appears to be a close link between cell cycle progression, cell migration, and expression of the integrin vitronectin receptor ␣ v ␤ 3 . 23, 28 This could provide one mechanism for the regulation of cell movement by the cell cycle. Still, it is not known if there is a direct effect of E2F on signaling events required for cell migration, or if the effects of agents that coordinately regulate cell proliferation and cell migration are due to an indirect, "inherent," ability of cells in late G 1 to migrate. This question is difficult to address because overexpression of cell cycle regulatory molecules affects the proportion of cells in G 1 , S, G 2 , and M. Specific E2F-regulated targets required for cell migration will have to be identified. Regardless of the molecular pathways that link G 1 progression and cell migration, there is now strong evidence that these two processes are closely coordinated. These findings have important clinical implications, for example, in relation to the promising use of coronary stents coated with growth-suppressing agents, such as rapamycin (sirolimus). 29 Growth-suppressing agents are now predicted to also inhibit SMC migration in vivo by causing cell cycle arrest.
How does the cell cycle control cell migration? Cells in mid-late G 1 have the greatest ability to migrate, whereas cells in the G 0 , S, G 2 , and M phases are stationary. Overexpression of CKIs (p21 Cip1 and p27 Kip1 ) blocks CDK2 activity, G 1 to S transition, and migration of SMCs. Furthermore, as shown by the studies of Díez-Juan and Andrés, 16 overexpression of a retinoblastoma protein (Rb) mutant that prevents release of the transcription factor complex E2F also inhibits cell migration. Thus, events downstream of Rb phosphorylation and release of E2F are likely to induce cell movement. How do these cell cycle events initiate cell migration? Overexpression of p27 Kip1 prevents lamellipodia formation and reorganization of actin filaments and focal adhesions. 16 Therefore, there is a link between CDK activity, Rb phosphorylation, and formation of a leading edge in the migrating cell. Further research is needed to elucidate the molecular mechanism behind the cell migration induced by CDK activity and Rb phosphorylation.
